Entrez Gene ID | 1277 |
---|---|
Official Gene Symbol | COL1A1 (GeneCards) |
Full name | collagen type I alpha 1 chain |
Location | 17q21.33 |
Other ids | Vega : OTTHUMG00000148674 MIM : 120150 HGNC : HGNC:2197 Ensembl : ENSG00000108821 |
Other names | OI1, OI2, OI3, OI4, EDSC, EDSARTH1 |
Summary | This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008] |
Found 15 variants in this database.
Variant ID | Entrez Gene ID | Gene | Chromsome | Start | End | Disease | Method |
---|---|---|---|---|---|---|---|
65 | 1277 | COL1A1 | 17 | 48262949 | 48262949 | Osteogenesis imperfecta type3 | Sanger |
96 | 1277 | COL1A1 | 17 | 48273282 | 48273286 | Osteogenesis imperfecta type2 | Sanger Subcloning |
97 | 1277 | COL1A1 | 17 | 48273282 | 48273286 | Osteogenesis imperfecta type2 | Sanger Subcloning |
98 | 1277 | COL1A1 | 17 | 48273282 | 48273286 | Osteogenesis imperfecta type2 | Sanger Subcloning |
255 | 1277 | COL1A1 | 17 | 48263148 | 48263148 | Osteogenesis imperfecta type2 | Sanger Subcloning NA |
256 | 1277 | COL1A1 | 17 | 48265940 | 48265948 | Osteogenesis imperfecta type2 | Sanger Subcloning NA |
257 | 1277 | COL1A1 | 17 | 48268787 | 48268787 | Osteogenesis imperfecta type2 | Sanger Subcloning NA |
589 | 1277 | COL1A1 | 17 | 48271508 | 48271508 | Osteogenesis imperfecta type2 | Sanger Subcloning NA Allele Specific Oligohibridization |
590 | 1277 | COL1A1 | 17 | 48271508 | 48271508 | Osteogenesis imperfecta type2 | Sanger Subcloning NA Allele Specific Oligohibridization |
591 | 1277 | COL1A1 | 17 | 48267056 | 48267056 | Osteogenesis imperfecta type2 | Sanger Subcloning NA Allele Specific Oligohibridization |
592 | 1277 | COL1A1 | 17 | 48267056 | 48267056 | Osteogenesis imperfecta type2 | Sanger Subcloning NA Allele Specific Oligohibridization RFLP |
593 | 1277 | COL1A1 | 17 | 48267056 | 48267056 | Osteogenesis imperfecta type2 | Sanger Subcloning NA Allele Specific Oligohibridization RFLP |
594 | 1277 | COL1A1 | 17 | 48267056 | 48267056 | Osteogenesis imperfecta type2 | Sanger Subcloning NA Allele Specific Oligohibridization RFLP |
19930 | 1277 | COL1A1 | 17 | 48276046 | 48276046 | Asymptomatic | Sanger Subcloning NA Allele Specific Oligohibridization RFLP HiSeq X Ten |
34684 | 1277 | COL1A1 | 17 | 48265940 | 48265948 | OI/EDS Combined Syndrome | Sanger Subcloning NA Allele Specific Oligohibridization RFLP HiSeq X Ten Sanger Sequencing Target NGS Sequencing |